0,903  0,002  Cholesterol antagonist
0,892  0,005  Antidiabetic
0,892  0,005  Cyclophilin D inhibitor
0,841  0,006  Caspase 9 stimulant
0,837  0,003  Angiogenesis stimulant
0,807  0,002  Amylase inhibitor
0,792  0,004  Cardioprotectant
0,800  0,015  Antiinflammatory
0,781  0,003  Antimutagenic
0,778  0,004  5 Hydroxytryptamine release stimulant
0,768  0,007  Antihypercholesterolemic
0,767  0,006  Chemoprotective
0,765  0,004  UGT1A9 substrate
0,760  0,004  Vasodilator, coronary
0,760  0,004  Hypoglycemic
0,757  0,004  NOS2 expression inhibitor
0,759  0,008  Radioprotector
0,758  0,007  Respiratory analeptic
0,753  0,005  Antioxidant
0,750  0,003  Alpha-N-acetylglucosaminidase inhibitor
0,753  0,007  Chemopreventive
0,729  0,014  Teratogen
0,717  0,005  Proliferative diseases treatment
0,713  0,002  VCAM1 expression inhibitor
0,707  0,004  Monophenol monooxygenase inhibitor
0,712  0,014  Embryotoxic
0,704  0,006  Vasodilator, peripheral
0,712  0,019  Transcription factor NF kappa B inhibitor
0,699  0,008  Antithrombotic
0,695  0,008  Analeptic
0,690  0,004  Antihypoxic
0,689  0,006  NOS3 expression inhibitor
0,688  0,009  Sensitization
0,680  0,005  Free radical scavenger
0,679  0,004  Interleukin agonist
0,668  0,004  Anesthetic general
0,670  0,007  Antiparasitic
0,693  0,032  Apoptosis agonist
0,658  0,003  Aldose reductase substrate
0,658  0,005  Genotoxic
0,655  0,005  Apoptosis antagonist
0,652  0,005  Antihelmintic
0,654  0,011  Mutagenic
0,643  0,004  Sulfotransferase substrate
0,644  0,008  Antidiabetic (type 2)
0,637  0,005  Antihypertriglyceridemic
0,632  0,006  UGT1A1 substrate
0,638  0,014  Antibacterial
0,621  0,003  Interleukin 2 agonist
0,628  0,010  Cytostatic
0,619  0,008  Antipyretic
0,607  0,007  UDP-glucuronosyltransferase substrate
0,610  0,010  Immunomodulator
0,610  0,010  Antipruritic, allergic
0,621  0,022  TNF expression inhibitor
0,608  0,010  Hepatic disorders treatment
0,595  0,004  ICAM1 expression inhibitor
0,606  0,016  Immunostimulant
0,593  0,006  Vascular (periferal) disease treatment
0,589  0,004  UGT2B4 substrate
0,612  0,028  CYP3A4 substrate
0,597  0,014  Stroke treatment
0,587  0,010  Nitric oxide antagonist
0,587  0,018  Carcinogenic
0,573  0,005  Septic shock treatment
0,572  0,005  Skin whitener
0,564  0,002  NADH dehydrogenase inhibitor
0,563  0,004  Mediator release inhibitor
0,563  0,005  Melanin inhibitor
0,564  0,009  Tumour necrosis factor alpha release inhibitor
0,559  0,005  Hepatoprotectant
0,569  0,017  Immunosuppressant
0,559  0,014  AR expression inhibitor
0,555  0,010  DNA damaging
0,547  0,003  Carcinogenic, group 1
0,540  0,005  NOS3 expression enhancer
0,536  0,002  UDP-glucose 4-epimerase inhibitor
0,590  0,056  Alpha-glucosidase inhibitor
0,532  0,003  Antineoplastic, alkylator
0,527  0,002  Triose-phosphate isomerase inhibitor
0,543  0,019  Cytotoxic
0,521  0,003  Antihemorrhagic
0,514  0,005  Interferon gamma antagonist
0,509  0,002  Selectin antagonist
0,516  0,012  DNA synthesis inhibitor
0,518  0,019  Antifungal
0,509  0,011  Vasodilator
0,515  0,018  Antiischemic
0,498  0,004  Antifungal enhancer
0,488  0,005  Platelet adhesion inhibitor
0,501  0,020  Lipoprotein disorders treatment
0,480  0,001  Mannosidase inhibitor
0,482  0,004  Neurotrophic factor enhancer
0,491  0,017  Antiamyloidogenic
0,470  0,003  AMP-activated protein kinase stimulant
0,467  0,007  Antihypotensive
0,468  0,014  Antineoplastic (endocrine cancer)
0,454  0,001  Alpha-mannosidase inhibitor
0,469  0,017  Amyloid beta aggregation inhibitor
0,479  0,028  Ulceration
0,481  0,036  Histamine release inhibitor
0,449  0,010  Antiviral (Herpes)
0,450  0,014  Myocardial infarction treatment
0,438  0,006  Protein kinase stimulant
0,434  0,004  Antispirochetal
0,433  0,005  Acute respiratory distress syndrome (ARDS) treatment
0,431  0,003  Photosensitizer
0,454  0,028  Caspase 3 stimulant
0,433  0,010  Non-steroidal antiinflammatory agent
0,425  0,003  Phosphofructokinase-1 inhibitor
0,426  0,004  Antihelmintic (Nematodes)
0,424  0,004  Xanthine oxidase inhibitor
0,436  0,021  Antineoplastic (lymphoma)
0,423  0,008  Antipruritic, non-allergic
0,418  0,004  Carbonic anhydrase VI inhibitor
0,474  0,064  Antiarthritic
0,424  0,021  UGT1A6 substrate
0,431  0,032  Antineoplastic (brain cancer)
0,406  0,007  Alkylator
0,403  0,008  Antidote
0,399  0,004  Neuropathy treatment
0,403  0,010  Antiviral (Influenza)
0,411  0,019  Antineoplastic (osteosarcoma)
0,412  0,024  Radiosensitizer
0,406  0,023  Antidiabetic symptomatic
0,391  0,009  Muscular dystrophy treatment
0,400  0,018  RNA-directed DNA polymerase inhibitor
0,403  0,025  Hypolipemic
0,383  0,004  Carbonic anhydrase XIII inhibitor
0,397  0,020  Eye irritation, high
0,405  0,029  Antiprotozoal (Leishmania)
0,380  0,008  Antidiarrheal
0,372  0,001  Sodium/glucose cotransporter inhibitor
0,375  0,005  Expectorant
0,377  0,011  Lipid peroxidase inhibitor
0,427  0,062  5 Hydroxytryptamine release inhibitor
0,420  0,058  Antileukemic
0,365  0,004  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,364  0,003  Carbonic anhydrase XIV inhibitor
0,368  0,007  Glutathione S-transferase substrate
0,367  0,008  Antidiabetic (type 1)
0,361  0,004  Antifungal (Cryptococcus)
0,397  0,041  CYP2C19 substrate
0,357  0,005  Hexokinase inhibitor
0,357  0,011  Peptidyltransferase inhibitor
0,396  0,050  Bone diseases treatment
0,368  0,023  Wound healing agent
0,406  0,061  CYP2C9 substrate
0,351  0,008  DNA polymerase I inhibitor
0,347  0,008  Aldehyde dehydrogenase inhibitor
0,347  0,008  Topoisomerase I inhibitor
0,384  0,044  Antimycobacterial
0,343  0,008  Cell adhesion inhibitor
0,347  0,013  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,355  0,023  Antineoplastic (sarcoma)
0,350  0,026  Cyclic AMP phosphodiesterase inhibitor
0,402  0,080  Calcium channel L-type activator
0,366  0,045  Antiosteoporotic
0,323  0,005  Cyclooxygenase 3 inhibitor
0,366  0,048  Spasmolytic
0,321  0,008  Nitric-oxide synthase stimulant
0,322  0,022  DNA methylase inhibitor
0,320  0,023  UGT2B7 substrate
0,306  0,009  Antitussive
0,308  0,012  Insulin secretagoues
0,373  0,077  GST A substrate
0,323  0,036  Antiulcerative
0,285  0,001  Sodium/glucose cotransporter 2 inhibitor
0,300  0,016  Insulin sensitizer
0,286  0,003  Chronic obstructive bronchitis treatment
0,323  0,042  Antineoplastic (liver cancer)
0,287  0,006  Mannose-6-phosphate isomerase inhibitor
0,281  0,003  Phosphodiesterase 6D inhibitor
0,345  0,067  Prostate cancer treatment
0,322  0,046  Platelet antagonist
0,281  0,004  Vanilloid 1 agonist
0,279  0,004  Interferon agonist
0,278  0,004  Interleukin 12 antagonist
0,270  0,005  Antiviral (Influenza B)
0,269  0,005  Transcription factor NF kappa B stimulant
0,283  0,019  Antiviral (Influenza A)
0,287  0,022  Restenosis treatment
0,274  0,010  Interleukin 4 antagonist
0,270  0,008  Dementia treatment
0,267  0,008  Vascular dementia treatment
0,323  0,065  Antineoplastic (ovarian cancer)
0,264  0,007  Choleretic
0,261  0,005  Carcinogenic, group 2A
0,262  0,008  Beta glucuronidase inhibitor
0,271  0,019  Hemostatic
0,257  0,005  DNA repair enzyme inhibitor
0,289  0,037  Antiviral (HIV)
0,260  0,009  Retinoprotector
0,272  0,022  UGT2B15 substrate
0,268  0,020  Interleukin 6 antagonist
0,272  0,024  Hair growth stimulant
0,253  0,006  CF transmembrane conductance regulator agonist
0,253  0,006  Mucolytic
0,251  0,005  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,248  0,004  Toll-Like receptor 4 antagonist
0,309  0,065  Antineoplastic (pancreatic cancer)
0,338  0,097  Atherosclerosis treatment
0,339  0,102  Antineoplastic (breast cancer)
0,292  0,055  Antineoplastic (renal cancer)
0,262  0,025  Diabetic nephropathy treatment
0,252  0,017  Psychosexual dysfunction treatment
0,332  0,097  Antiobesity
0,263  0,031  Thrombolytic
0,245  0,013  Antiviral (Ebola)
0,245  0,014  Carcinogenic, group 2B
0,306  0,079  CYP2D6 substrate
0,230  0,004  Phosphorylase inhibitor
0,356  0,134  Antineoplastic (solid tumors)
0,232  0,016  Antineoplastic antibiotic
0,225  0,012  Carbonic anhydrase III inhibitor
0,238  0,026  Topoisomerase II inhibitor
0,219  0,007  Adenylate cyclase stimulant
0,229  0,020  Cell wall synthesis inhibitor
0,229  0,021  Antihyperlipoproteinemic
0,228  0,021  SULT1A3 substrate
0,225  0,022  UGT2B10 substrate
0,215  0,012  Growth stimulant
0,203  0,002  Glucose-6-phosphate isomerase inhibitor
0,204  0,003  Interferon inducer
0,223  0,022  Adenylate cyclase inhibitor
0,220  0,020  Antirickettsial
0,221  0,024  ATPase inhibitor
0,222  0,025  Uterine stimulant
0,221  0,025  Antiprotozoal (Coccidial)
0,198  0,003  Glucosylceramidase inhibitor
0,225  0,031  Phospholipase C inhibitor
0,198  0,004  Phosphodiesterase VI inhibitor
0,206  0,014  Topoisomerase II alpha inhibitor
0,200  0,010  Sphingomyelinase inhibitor
0,272  0,082  Antineoplastic (melanoma)
0,211  0,023  Neurotrophic factor
0,271  0,084  CYP1A2 substrate
0,189  0,002  Heparanase inhibitor
0,201  0,016  Beta amyloid protein antagonist
0,190  0,005  Glutamate release inhibitor
0,231  0,049  Myocardial ischemia treatment
0,245  0,063  Interleukin antagonist
0,182  0,001  Sodium/glucose cotransporter 1 inhibitor
0,184  0,004  Antibiotic Glycopeptide-like
0,183  0,005  Antiviral (Dengue virus)
0,262  0,084  Antituberculosic
0,216  0,039  Liver fibrosis treatment
0,191  0,013  Alcohol dehydrogenase inhibitor
0,217  0,042  Antineoplastic (gastric cancer)
0,202  0,028  Antiviral (Hepatitis B)
0,260  0,086  GST M1-1 substrate
0,187  0,014  Antibiotic
0,219  0,049  Sepsis treatment
0,187  0,018  UGT2B1 substrate
0,219  0,050  Diabetic retinopathy treatment
0,207  0,040  Cystic fibrosis treatment
0,170  0,004  Gaucher disease treatment
0,175  0,009  Ca2+-transporting ATPase inhibitor
0,238  0,073  Cardiodepressant
0,260  0,097  Metabolic disease treatment
0,189  0,027  Cystathionine beta-synthase inhibitor
0,167  0,005  GABA aminotransferase inhibitor
0,164  0,002  Cholesterol absorption inhibitor
0,222  0,061  Sedative
0,272  0,111  Antineoplastic (small cell lung cancer)
0,235  0,081  Acute neurologic disorders treatment
0,183  0,032  Toll-Like receptor 2 antagonist
0,265  0,117  Antineoplastic (lung cancer)
0,158  0,010  Antiviral (Rhinovirus)
0,161  0,013  Cell adhesion molecule inhibitor
0,155  0,010  Antifungal (Candida)
0,173  0,029  Antiviral (Poxvirus)
0,248  0,104  Antineoplastic (colorectal cancer)
0,189  0,045  Antineoplastic (squamous cell carcinoma)
0,183  0,041  Alkaline phosphatase inhibitor
0,250  0,109  CTGF expression inhibitor
0,171  0,030  Antineoplastic antimetabolite
0,195  0,055  Anticoagulant
0,141  0,005  Antimycoplasmal
0,161  0,025  HDL-cholesterol increasing
0,151  0,015  UGT2B11 substrate
0,142  0,007  Na+ K+ transporting ATPase inhibitor
0,172  0,037  Protein-tyrosine phosphatase 1B inhibitor
0,187  0,053  Acaricide
0,204  0,071  Osteoarthritis treatment
0,149  0,017  Thioredoxin inhibitor
0,185  0,053  Protein-tyrosine phosphatase inhibitor
0,210  0,080  Antineoplastic (glioblastoma multiforme)
0,298  0,170  Alzheimer's disease treatment
0,186  0,059  UGT1A3 substrate
0,180  0,054  Phospholipase A2 inhibitor
0,134  0,008  Antiviral (Herpesvirus 3, Human)
0,233  0,109  Antineoplastic (multiple myeloma)
0,134  0,013  Histone deacetylase stimulant
0,134  0,013  Histone deacetylase SIRT1 stimulant
0,145  0,025  Uric acid excretion stimulant
0,155  0,036  Heat shock protein 70 antagonist
0,131  0,013  Glycine receptor antagonist
0,161  0,043  Skin irritative effect
0,148  0,030  Aldehyde dehydrogenase substrate
0,153  0,036  Microtubule formation inhibitor
0,126  0,010  Narcotic antagonist
0,210  0,094  Antineoplastic (glioma)
0,192  0,077  Abortion inducer
0,162  0,048  Hearing loss treatment
0,265  0,150  Antiprotozoal
0,156  0,042  Antibacterial (Helicobacter pylori)
0,155  0,043  Antihelmintic (Trematoda)
0,187  0,076  DNA methyltransferase I inhibitor
0,121  0,009  Protein 50S ribosomal subunit inhibitor
0,147  0,037  SULT1A1 substrate
0,183  0,073  Antiviral (Hepatitis)
0,144  0,035  Constipation treatment
0,140  0,031  Antifungal (Pneumocystis)
0,203  0,097  Antineoplastic (lymphocytic leukemia)
0,217  0,112  Antineoplastic (colon cancer)
0,167  0,063  Diuretic
0,159  0,057  Antiacne
0,103  0,003  Antibiotic Aminoglycoside-like
0,167  0,069  Arachidonic acid antagonist
0,137  0,040  Antischistosomal
0,204  0,108  Antiviral (West Nile virus)
0,100  0,004  Cytokine production stimulant
0,137  0,043  Alcohol dehydrogenase substrate
0,111  0,017  SULT1A2 substrate
0,142  0,049  Cholesterol synthesis inhibitor
0,175  0,084  P-glycoprotein inhibitor
0,106  0,015  Antimetabolite
0,188  0,098  Antialcoholic
0,114  0,024  ATPase (Vacuolar H+) inhibitor
0,106  0,016  Protein kinase C eta inhibitor
0,093  0,002  Ceramide glucosyltransferase inhibitor
0,133  0,043  Antiviral (CMV)
0,127  0,038  Adenylate kinase inhibitor
0,102  0,014  Antitreponemal
0,098  0,010  Factor IXa inhibitor
0,128  0,041  Estrogen antagonist
0,192  0,107  Antineoplastic (cervical cancer)
0,154  0,070  Antinephritic
0,253  0,169  Antineoplastic (myeloid leukemia)
0,188  0,105  Antiglaucomic
0,088  0,006  Adenine nucleotide translocase inhibitor
0,141  0,059  Carcinogenic, group 3
0,085  0,003  Uridine phosphorylase inhibitor
0,086  0,005  Arginase inhibitor
0,084  0,004  Protein 30S ribosomal subunit inhibitor
0,098  0,018  Aldose reductase inhibitor
0,087  0,008  Adenosine deaminase inhibitor
0,126  0,049  Gout treatment
0,097  0,020  Carbonic anhydrase XII inhibitor
0,094  0,018  Neuraminidase (influenza) inhibitor
0,222  0,146  Angiogenesis inhibitor
0,254  0,180  Antiparkinsonian
0,103  0,030  Vanilloid agonist
0,091  0,020  Estrogen agonist
0,099  0,028  Peroxisome proliferator-activated receptor gamma agonist
0,115  0,044  Potassium channel (Ca-activated) activator
0,085  0,016  Toll-Like receptor 2 agonist
0,094  0,025  Glycine receptor agonist
0,107  0,040  Actinic keratosis treatment
0,120  0,053  Protein kinase C gamma inhibitor
0,090  0,024  Carbamoyl phosphate synthetase inhibitor
0,082  0,016  Andropause treatment
0,074  0,009  Equilibrative nucleoside transport protein inhibitor
0,066  0,002  Vanilloid 2 agonist
0,086  0,022  Antidote, heavy metal
0,105  0,041  Aminoacyl-tRNA synthetase inhibitor
0,150  0,086  UGT1A4 substrate
0,085  0,022  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,072  0,009  Phosphoglycerate kinase inhibitor
0,127  0,065  Gastritis treatment
0,083  0,021  SULT2A1 substrate
0,145  0,083  UGT2B9 substrate
0,181  0,120  Antineoplastic (non-small cell lung cancer)
0,116  0,056  Neutropenia treatment
0,104  0,044  SULT1E1 substrate
0,109  0,050  Anabolic
0,071  0,013  Squalene epoxidase inhibitor
0,173  0,117  Antineoplastic enhancer
0,074  0,018  Leukotriene B4 antagonist
0,100  0,044  Restless leg syndrome treatment
0,064  0,008  Guanylate cyclase inhibitor
0,082  0,026  Carbonic anhydrase IX inhibitor
0,080  0,025  Purinergic P2X1 antagonist
0,086  0,032  Carbonic anhydrase VA inhibitor
0,066  0,012  Thymidine kinase inhibitor
0,085  0,033  Carbonic anhydrase inhibitor
0,080  0,029  Protein kinase C beta inhibitor
0,200  0,149  Gastrin inhibitor
0,201  0,150  Hypoxia-inducible factor 1 alpha inhibitor
0,086  0,037  Lipase inhibitor
0,066  0,018  Glucose-6-phosphate translocase inhibitor
0,075  0,027  Nitric oxide donor
0,071  0,024  Sphingosine kinase inhibitor
0,075  0,029  Neuraminidase inhibitor
0,080  0,035  Carbonic anhydrase V inhibitor
0,046  0,002  Antibiotic Anthracycline-like
0,083  0,040  Adenosine A3 receptor antagonist
0,047  0,004  Toll-Like receptor 4 agonist
0,129  0,086  Antineoplastic (carcinoma)
0,087  0,046  Thioredoxin reductase inhibitor
0,161  0,119  Growth factor agonist
0,067  0,026  Beta 2 adrenoreceptor agonist
0,161  0,123  Pneumotoxic
0,191  0,152  Tyrosine 3 hydroxylase inhibitor
0,108  0,070  Acetylcholine release stimulant
0,039  0,002  Telomerase stimulant
0,086  0,049  Estrogen-related receptor beta agonist
0,058  0,021  Carbonic anhydrase VII inhibitor
0,041  0,005  GRP78 expression inhibitor
0,046  0,010  Nucleoside transporters inhibitor
0,107  0,073  Interleukin 1b antagonist
0,064  0,029  Lipocortins synthesis agonist
0,041  0,008  Protein kinase C beta I inhibitor
0,078  0,047  Glutamate dehydrogenase inhibitor
0,061  0,032  Postmenopausal disorders treatment
0,035  0,006  1,3-Beta-glucan synthase inhibitor
0,186  0,158  Transcription factor STAT inhibitor
0,049  0,021  Somatostatin 1 antagonist
0,207  0,179  Sodium/bile acid cotransporter inhibitor
0,053  0,027  Factor III inhibitor
0,084  0,058  Antiviral (Trachoma)
0,070  0,044  Potassium channel large-conductance Ca-activated activator
0,035  0,010  Somatostatin 4 antagonist
0,030  0,005  Isoleucine-tRNA ligase inhibitor
0,209  0,184  FMO1 substrate
0,034  0,010  Adenosine A1 receptor agonist
0,062  0,039  Biliverdin reductase inhibitor
0,032  0,009  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,065  0,043  CDC25B inhibitor
0,091  0,069  Lanosterol 14 alpha demethylase inhibitor
0,027  0,005  Ileal bile acid transport inhibitor
0,044  0,024  Sphingosine kinase 1 inhibitor
0,116  0,096  Antineoplastic (uterine cancer)
0,207  0,188  Inflammatory Bowel disease treatment
0,094  0,075  Carbonic anhydrase XV inhibitor
0,052  0,034  Prolyl endopeptidase inhibitor
0,059  0,042  Prostaglandin EP2 antagonist
0,056  0,038  Carbonic anhydrase VB inhibitor
0,027  0,010  Inosine monophosphate dehydrogenase 1 inhibitor
0,064  0,046  Leukotriene antagonist
0,095  0,078  Antiprotozoal (Toxoplasma)
0,049  0,032  Cholesterol esterase inhibitor
0,091  0,074  Bronchodilator
0,131  0,115  Antianginal
0,095  0,079  DNA intercalator
0,037  0,022  Estrogen receptor alpha agonist
0,055  0,039  Carbonic anhydrase II inhibitor
0,022  0,007  Adenosine A2 receptor agonist
0,020  0,006  O6-alkylguanine-DNA alkyltransferase inhibitor
0,045  0,032  Neuraminidase (Influenza A) inhibitor
0,082  0,068  Interleukin 5 antagonist
0,019  0,008  Adenosine A2a receptor agonist
0,052  0,041  Maillard reaction inhibitor
0,045  0,035  Microtubule stabilization
0,029  0,019  Hypoxanthine phosphoribosyltransferase inhibitor
0,178  0,168  Transcription factor STAT3 inhibitor
0,014  0,004  Purinergic P2Y2 agonist
0,030  0,020  Thiazolidinedione
0,016  0,008  Adenosine A2b receptor agonist
0,068  0,060  CDC25A inhibitor
0,033  0,025  Sodium-dependent vitamin C transporter 2 inhibitor
0,057  0,050  HIV-1 integrase (3'-Processing) inhibitor
0,026  0,018  Thymidine phosphorylase inhibitor
0,016  0,009  Antibiotic Macrolide-like
0,021  0,014  Corticosteroid-like
0,093  0,087  Chelator
0,063  0,056  Hypercalcemia treatment
0,064  0,059  Anticholelithogenic
0,032  0,027  Fumarate hydratase inhibitor
0,186  0,182  5 Hydroxytryptamine uptake stimulant
0,031  0,026  Melatonin 2 agonist
0,129  0,125  Antiviral (Hepatitis C)
0,050  0,046  Argininosuccinate synthase inhibitor
0,048  0,045  Acyl-CoA dehydrogenase inhibitor
0,050  0,047  Sphingosine kinase 2 inhibitor
0,167  0,165  Huntington's disease treatment
0,026  0,025  Estrogen receptor beta agonist
0,024  0,022  Somatostatin 2 antagonist
0,045  0,044  Beta 2 adrenoreceptor antagonist
0,013  0,012  Purinergic receptor agonist
0,013  0,012  Purinergic P2 agonist
0,050  0,049  Adenosine A1 receptor antagonist
0,003  0,002  Purinergic P2Y6 agonist

